Summit Therapeutics Inc vs Veritone Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Summit Therapeutics Inc is far larger — about 107.4× Veritone Inc's market cap. Which is the better fit depends on your goals.
| SMMT | VERI | |
|---|---|---|
Market Cap | $10.48B | $97.60M |
Sector | Health | Technology |
52-Week High | $29.32 | $8.39 |
52-Week Low | $13.05 | $1.02 |
Enterprise Value | $9.90B | $129.63M |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →